Delivery Order SPE2DE21D7009-SPE2D626F03Y1
- Not listed
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corp, was awarded a $1,867.00 fixed-price delivery order with economic price adjustment on November 28, 2025, for pain management medical devices and services. The contract, identified as PAIN MANAGEMENT (4570238376), is set to be completed by December 5, 2025, with performance occurring in Valencia, California. This delivery order was funded by the Medical Supply Chain, a defense-related procurement entity, and represents...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, has been awarded a delivery order valued at $1,825.75 for pain management medical devices under a fixed-price contract with economic price adjustment. The award was issued on May 8, 2025, with an ultimate completion date of May 16, 2025, and will be performed in Valencia, California. This delivery order is issued under the company's larger indefinite delivery contract with the Defense Logistics Agency Troop...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, was awarded a $1,867 fixed-price delivery order with economic price adjustment on September 9, 2025, for pain management medical devices. The contract is set to be completed by September 16, 2025, with performance taking place in Valencia, California. This delivery order is issued under Boston Scientific Neuromodulation's larger indefinite delivery contract (SPE2DE) with the Defense Logistics Agency Troop...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, has been awarded a $41,406.68 fixed-price delivery order with economic price adjustment for pain management medical devices and services. The award, issued on September 9, 2025, with an ultimate completion date of September 16, 2025, carries no set-aside designation and will be performed in Valencia, California. This delivery order is issued under Boston Scientific Neuromodulation's larger indefinite...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, was awarded a delivery order valued at $31,877.20 on December 15, 2025, for pain management medical devices and services. This fixed-price contract with economic price adjustment has a completion date of December 29, 2025, and will be performed in Valencia, California. The award carries no small business set-aside designation and is funded by the Medical Supply Chain, a defense-related procurement entity...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corp, was awarded a delivery order valued at $36,589.22 on September 9, 2025, for pain management medical devices and services. This fixed-price contract with economic price adjustment has a completion date of September 19, 2025, and is being performed in Valencia, California. The award carries no set-aside designation, indicating open competition in the federal marketplace. The contract is funded through the Medical...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, was awarded a delivery order valued at $36,654.68 on December 15, 2025, for pain management medical devices and services. This fixed-price contract with economic price adjustment has an ultimate completion date of December 29, 2025 and will be performed in Valencia, California. The award is issued under a larger indefinite delivery contract (SPE2DE) with the Defense Logistics Agency Troop Support Medical...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, has been awarded a $1,825.75 delivery order for pain management medical devices under contract 4570282591. The award, issued on November 28, 2025, with an ultimate completion date of December 5, 2025, utilizes a fixed-price contract with economic price adjustment pricing structure. The contract is not designated for any small business set-aside and will be performed in Valencia, California. This delivery order...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corp, received a delivery order award valued at $38,124.85 on December 19, 2025, for pain management medical devices and services. This fixed-price delivery order with economic price adjustment will be completed by December 29, 2025, and represents a child contract issued under a larger indefinite delivery vehicle—the SPE2DE contract held by Boston Scientific Neuromodulation with the Defense Logistics Agency Troop...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, has been awarded a delivery order valued at $1,825.75 under the Defense Logistics Agency Troop Support Medical branch's larger indefinite delivery contract (SPE2DE) for pain management solutions. The award, issued on December 15, 2025, with an ultimate completion date of December 31, 2025, utilizes a fixed-price contract structure with economic price adjustment provisions. Work will be performed at the...
- SPE2DE21D7009Indefinite Delivery Contract
- SPE2DE21D7009-SPE2D626F03Y1Delivery Order
Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, has been awarded a delivery order valued at $1,825.75 for pain management solutions under contract number 4570237134. This fixed-price delivery order with economic price adjustment authority was issued on November 28, 2025, with an ultimate completion date of December 5, 2025, and will be performed in Valencia, California. The award was issued without a small business set-aside designation by the Medical Supply Chain, a defense-related procurement entity within the Department of Defense, to support federal pain management initiatives. This delivery order is issued against Boston Scientific Neuromodulation's larger indefinite delivery contract (SPE2DE) with the Defense Logistics Agency Troop Support Medical branch, valued at $83.1 million through August 16, 2026. The parent company and subsidiary specialize in providing non-opioid pain management technologies, including spinal cord stimulation systems, implantable pain pumps, and radiofrequency ablation devices, to military treatment facilities and Veterans Affairs medical centers nationwide. Boston Scientific's comprehensive neuromodulation solutions, including proprietary RestoreSensor and Spectra WaveWriter systems along with associated accessories, training, and technical support, enable the federal government to deliver advanced pain management capabilities to service members and veterans managing chronic pain from traumatic injuries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 11/27/25 |